Potent Inhibition of Chikungunya Virus Entry by a Pyrazole–Benzene Derivative: A Computational Study Targeting the E1–E2 Glycoprotein Complex
International Journal of Molecular Sciences · 05.07.2025 · 26 (13) · 6480
DOI: 10.3390/ijms26136480 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.07.2025. Verfasst von Md Mohibur Rahman und 6 weiteren Autor:innen. Beteiligte Einrichtung: One Health Laboratory, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Mohakhali, Dhaka 1212, Bangladesh. Hauptthemen laut MEDLINE: Chikungunya virus, Antiviral Agents, Virus Internalization, Viral Envelope Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: governments of Bangladesh, Global Affairs Canada.
Abstract (Originalsprache)
The Chikungunya virus (CHIKV) continues to pose a significant global health challenge due to the absence of effective antiviral treatments and limited vaccine availability. This study employed a comprehensive in silico workflow, incorporating high-throughput virtual screening, binding free-energy calculations, ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis, and 200 ns molecular dynamics (MD) simulations, to identify new inhibitors targeting the E1–E2 glycoprotein complex, crucial for CHIKV entry and membrane fusion. Four promising candidates were identified from a library of 20,000 compounds, with CID 136801451 showing the most potent binding (docking score: −10.227; ΔG_bind: −51.53 kcal/mol). The top four compounds exhibited favorable ADMET profiles, meeting nearly all criteria. MD simulations confirmed stable binding and strong interactions between CID 136801451 and the E1–E2 complex, evidenced by consistently low RMSD values. These findings highlight CID 136801451 as a promising CHIKV entry inhibitor, warranting further in vitro and in vivo evaluation to advance the development of effective anti-CHIKV therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- One Health Laboratory, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Mohakhali, Dhaka 1212, Bangladesh.
- Department of Microbiology and Immunology, University of Louisville, Louisville, KY 40202, USA.
ORCID-Profile: Md Belayet Hasan Limon, Tanvir Ahmed Saikat, Abdul Hadi Nahid, Mohammad Mamun Alam, Mohammed Ziaur Rahman
Förderung
- governments of Bangladesh
- Global Affairs Canada
Zitieren
APA
Rahman, M. M., Limon, M. B. H., Saikat, T. A., Saha, P., Nahid, A. H., Alam, M. M., & Rahman, M. Z. (2025). Potent Inhibition of Chikungunya Virus Entry by a Pyrazole–Benzene Derivative: A Computational Study Targeting the E1–E2 Glycoprotein Complex. International Journal of Molecular Sciences, 26(13), 6480. https://doi.org/10.3390/ijms26136480
Vancouver
Rahman MM, Limon MBH, Saikat TA, Saha P, Nahid AH, Alam MM, et al. Potent Inhibition of Chikungunya Virus Entry by a Pyrazole–Benzene Derivative: A Computational Study Targeting the E1–E2 Glycoprotein Complex. International Journal of Molecular Sciences. 2025;26(13):6480. doi:10.3390/ijms26136480
BibTeX
@article{Rahman2025,
author = {Rahman, Md Mohibur and Limon, Md Belayet Hasan and Saikat, Tanvir Ahmed and Saha, Poulomi and Nahid, Abdul Hadi and Alam, Mohammad Mamun and Rahman, Mohammed Ziaur},
title = {Potent Inhibition of Chikungunya Virus Entry by a Pyrazole–Benzene Derivative: A Computational Study Targeting the E1–E2 Glycoprotein Complex},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6480},
doi = {10.3390/ijms26136480}
}
EUVIMED